-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | IL0011224156 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 67M |
|---|---|
| PE Ratio | None |
| Target Price | 3.2067 |
| Beta | 2.31 |
| Dividend Yield | None |
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ICCM using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025